Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

28.08
+2.6910.58%
Post-market: 28.280.2050+0.73%19:50 EDT
Volume:199.20K
Turnover:5.62M
Market Cap:296.22M
PE:-8.97
High:30.00
Open:25.70
Low:25.41
Close:25.39
52wk High:30.00
52wk Low:5.26
Shares:10.55M
Float Shares:4.98M
Volume Ratio:0.95
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1298
EPS(LYR):-4.6702
ROE:-540.01%
ROA:-14.05%
PB:32.40
PE(LYR):-6.01

Loading ...

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

GlobeNewswire
·
Jul 22

Biodesix management to meet virtually with Craig Hallum

TIPRANKS
·
Jul 09

Roth Capital Initiates Biodesix at Buy With $32 Price Target

MT Newswires Live
·
Jun 25

Biodesix Initiated at Buy by Roth Capital

Dow Jones
·
Jun 25

Roth starts Biodesix at Buy, says positioned to deliver durable growth

TIPRANKS
·
Jun 25

Biodesix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jun 18

Biodesix price target raised to $27 from $22 at Canaccord

TIPRANKS
·
Jun 18

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Reuters
·
Jun 18

Biodesix Inc : Canaccord Genuity Raises Target Price to $27 From $22

THOMSON REUTERS
·
Jun 18

HC Wainwright Initiates Biodesix at Buy With $26 Price Target

MT Newswires Live
·
Jun 15

Biodesix Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 15

Biodesix, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $26

THOMSON REUTERS
·
Jun 15

U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology

Reuters
·
Jun 15

Biodesix files to sell 375,000 shares of common stock for holders

TIPRANKS
·
May 22

Biodesix leadership to attend William Blair Growth Stock Conference presentation

Reuters
·
May 21

Biodesix to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 21

Biodesix Shareholders Approve Directors and Governance Measures

TIPRANKS
·
May 21

Biodesix shareholders elect Class III directors at annual meeting

Reuters
·
May 21

Biodesix to present real-world clinical, economic data for Nodify Lung testing at ATS 2026

Reuters
·
May 11

Biodesix Faces Mounting Reimbursement and Enforcement Risks as Evolving Payer Policies Threaten Revenue Stability

TIPRANKS
·
May 06